{"id":4867,"date":"2015-03-18T10:28:45","date_gmt":"2015-03-18T10:28:45","guid":{"rendered":"http:\/\/www.neurodegenerationresearch.eu\/?p=4867"},"modified":"2015-03-26T09:35:20","modified_gmt":"2015-03-26T09:35:20","slug":"first-venture-capital-fund-to-focus-solely-on-dementia-research","status":"publish","type":"post","link":"https:\/\/neurodegenerationresearch.eu\/sk\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/","title":{"rendered":"First venture capital fund to focus solely on dementia research"},"content":{"rendered":"<p><em><strong>The Dementia Discovery Fund, which is being established by the UK government with initial commitments totalling $100 million, brings together leading pharmaceutical companies, the UK government and Alzheimer\u2019s Research UK to address the rising threat posed by dementia by supporting research into future treatments.<\/strong><\/em><\/p>\n<p>The fund aims to identify and nurture promising new avenues of research from around the world in the field of dementia. It is hoped that by providing critical financial support and expert advice during the early stages of research, the development of innovative new treatments for this disease could be accelerated.<\/p>\n<p>The Dementia Discovery Fund will be structured as a typical venture capital fund, but will be the first to focus solely on dementia research. The Fund will comb the global research community for the most promising early stage research to invest in. A scientific advisory board of representatives from each of the partner organisations will provide expert scientific input during the selection of research programmes, as well as providing ongoing advice during pre-clinical and early clinical development. Partners will then be sought for the progression of promising assets through the clinical development pipeline, the intention being that proceeds from licensing or sale of such programmes will be returned to the Fund and its investors. The Fund will appoint a professional investment manager in due course, which will be responsible for its financial governance and investment decisions.<\/p>\n<p>Source: Reuters<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Dementia Discovery Fund, which is being established by the [&hellip;]<\/p>\n<a href=\"https:\/\/neurodegenerationresearch.eu\/sk\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/\">View Post<\/a>","protected":false},"author":3,"featured_media":3365,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[22],"tags":[72,128,89,202],"class_list":["post-4867","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-news","tag-dementia","tag-drug-target","tag-funding","tag-venture-capital"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First venture capital fund to focus solely on dementia research - JPND Neurodegenerative Disease Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First venture capital fund to focus solely on dementia research - JPND Neurodegenerative Disease Research\" \/>\n<meta property=\"og:description\" content=\"The Dementia Discovery Fund, which is being established by the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/\" \/>\n<meta property=\"og:site_name\" content=\"JPND Neurodegenerative Disease Research\" \/>\n<meta property=\"article:published_time\" content=\"2015-03-18T10:28:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2015-03-26T09:35:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2014\/09\/Research-Funding.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1754\" \/>\n\t<meta property=\"og:image:height\" content=\"1240\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"jpnd\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JPNDeurope\" \/>\n<meta name=\"twitter:site\" content=\"@JPNDeurope\" \/>\n<meta name=\"twitter:label1\" content=\"Autor\" \/>\n\t<meta name=\"twitter:data1\" content=\"jpnd\" \/>\n\t<meta name=\"twitter:label2\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 min\u00fata\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/\"},\"author\":{\"name\":\"jpnd\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/person\\\/a97e49cae588ead81db59e48a4e63c2a\"},\"headline\":\"First venture capital fund to focus solely on dementia research\",\"datePublished\":\"2015-03-18T10:28:45+00:00\",\"dateModified\":\"2015-03-26T09:35:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/\"},\"wordCount\":243,\"publisher\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2014\\\/09\\\/Research-Funding.jpg\",\"keywords\":[\"Dementia\",\"Drug Target\",\"Funding\",\"Venture Capital\"],\"articleSection\":[\"Research News (General)\"],\"inLanguage\":\"sk-SK\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/\",\"name\":\"First venture capital fund to focus solely on dementia research - JPND Neurodegenerative Disease Research\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2014\\\/09\\\/Research-Funding.jpg\",\"datePublished\":\"2015-03-18T10:28:45+00:00\",\"dateModified\":\"2015-03-26T09:35:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2014\\\/09\\\/Research-Funding.jpg\",\"contentUrl\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2014\\\/09\\\/Research-Funding.jpg\",\"width\":1754,\"height\":1240},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/2015\\\/03\\\/first-venture-capital-fund-to-focus-solely-on-dementia-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First venture capital fund to focus solely on dementia research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#website\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\",\"name\":\"JPND Neurodegenerative Disease Research\",\"description\":\"Neurodegenerative Disease Research\",\"publisher\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#organization\",\"name\":\"JPND\",\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.neurodegenerationresearch.eu\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/logo.png\",\"width\":248,\"height\":129,\"caption\":\"JPND\"},\"image\":{\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/JPNDeurope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/#\\\/schema\\\/person\\\/a97e49cae588ead81db59e48a4e63c2a\",\"name\":\"jpnd\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g\",\"caption\":\"jpnd\"},\"url\":\"https:\\\/\\\/neurodegenerationresearch.eu\\\/sk\\\/author\\\/jpnd\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First venture capital fund to focus solely on dementia research - JPND Neurodegenerative Disease Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/","og_locale":"sk_SK","og_type":"article","og_title":"First venture capital fund to focus solely on dementia research - JPND Neurodegenerative Disease Research","og_description":"The Dementia Discovery Fund, which is being established by the [&hellip;]","og_url":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/","og_site_name":"JPND Neurodegenerative Disease Research","article_published_time":"2015-03-18T10:28:45+00:00","article_modified_time":"2015-03-26T09:35:20+00:00","og_image":[{"width":1754,"height":1240,"url":"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2014\/09\/Research-Funding.jpg","type":"image\/jpeg"}],"author":"jpnd","twitter_card":"summary_large_image","twitter_creator":"@JPNDeurope","twitter_site":"@JPNDeurope","twitter_misc":{"Autor":"jpnd","Predpokladan\u00fd \u010das \u010d\u00edtania":"1 min\u00fata"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/#article","isPartOf":{"@id":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/"},"author":{"name":"jpnd","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/person\/a97e49cae588ead81db59e48a4e63c2a"},"headline":"First venture capital fund to focus solely on dementia research","datePublished":"2015-03-18T10:28:45+00:00","dateModified":"2015-03-26T09:35:20+00:00","mainEntityOfPage":{"@id":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/"},"wordCount":243,"publisher":{"@id":"https:\/\/neurodegenerationresearch.eu\/#organization"},"image":{"@id":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/#primaryimage"},"thumbnailUrl":"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2014\/09\/Research-Funding.jpg","keywords":["Dementia","Drug Target","Funding","Venture Capital"],"articleSection":["Research News (General)"],"inLanguage":"sk-SK"},{"@type":"WebPage","@id":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/","url":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/","name":"First venture capital fund to focus solely on dementia research - JPND Neurodegenerative Disease Research","isPartOf":{"@id":"https:\/\/neurodegenerationresearch.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/#primaryimage"},"image":{"@id":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/#primaryimage"},"thumbnailUrl":"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2014\/09\/Research-Funding.jpg","datePublished":"2015-03-18T10:28:45+00:00","dateModified":"2015-03-26T09:35:20+00:00","breadcrumb":{"@id":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/"]}]},{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/#primaryimage","url":"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2014\/09\/Research-Funding.jpg","contentUrl":"https:\/\/neurodegenerationresearch.eu\/wp-content\/uploads\/2014\/09\/Research-Funding.jpg","width":1754,"height":1240},{"@type":"BreadcrumbList","@id":"https:\/\/neurodegenerationresearch.eu\/2015\/03\/first-venture-capital-fund-to-focus-solely-on-dementia-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neurodegenerationresearch.eu\/"},{"@type":"ListItem","position":2,"name":"First venture capital fund to focus solely on dementia research"}]},{"@type":"WebSite","@id":"https:\/\/neurodegenerationresearch.eu\/#website","url":"https:\/\/neurodegenerationresearch.eu\/","name":"JPND Neurodegenerative Disease Research","description":"Neurodegenerative Disease Research","publisher":{"@id":"https:\/\/neurodegenerationresearch.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neurodegenerationresearch.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sk-SK"},{"@type":"Organization","@id":"https:\/\/neurodegenerationresearch.eu\/#organization","name":"JPND","url":"https:\/\/neurodegenerationresearch.eu\/","logo":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2022\/03\/logo.png","contentUrl":"https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2022\/03\/logo.png","width":248,"height":129,"caption":"JPND"},"image":{"@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/JPNDeurope"]},{"@type":"Person","@id":"https:\/\/neurodegenerationresearch.eu\/#\/schema\/person\/a97e49cae588ead81db59e48a4e63c2a","name":"jpnd","image":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b3244fc6099279fad29cb751cb709c5ee57befcda19ef0b44a4f0067989d7f7e?s=96&d=mm&r=g","caption":"jpnd"},"url":"https:\/\/neurodegenerationresearch.eu\/sk\/author\/jpnd\/"}]}},"_links":{"self":[{"href":"https:\/\/neurodegenerationresearch.eu\/sk\/wp-json\/wp\/v2\/posts\/4867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neurodegenerationresearch.eu\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neurodegenerationresearch.eu\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/sk\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/sk\/wp-json\/wp\/v2\/comments?post=4867"}],"version-history":[{"count":0,"href":"https:\/\/neurodegenerationresearch.eu\/sk\/wp-json\/wp\/v2\/posts\/4867\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/sk\/wp-json\/wp\/v2\/media\/3365"}],"wp:attachment":[{"href":"https:\/\/neurodegenerationresearch.eu\/sk\/wp-json\/wp\/v2\/media?parent=4867"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/sk\/wp-json\/wp\/v2\/categories?post=4867"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neurodegenerationresearch.eu\/sk\/wp-json\/wp\/v2\/tags?post=4867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}